Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M704070200 on August 8, 2007

J. Biol. Chem., Vol. 282, Issue 39, 28385-28394, September 28, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/39/28385    most recent
M704070200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tubb, M. R.
Right arrow Articles by Davidson, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tubb, M. R.
Right arrow Articles by Davidson, W. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Modulation of Apolipoprotein A-IV Lipid Binding by an Interaction between the N and C Termini*

Matthew R. Tubb{ddagger}, R. A. Gangani D. Silva{ddagger}, Kevin J. Pearson§, Patrick Tso{ddagger}, Min Liu{ddagger}, and W. Sean Davidson{ddagger}1

From the {ddagger}Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio 45237 and the §Laboratory of Experimental Gerontology, NIA, National Institutes of Health, Baltimore, Maryland 21224

Apolipoprotein A-IV (apoA-IV) is a 376-amino acid exchangeable apolipoprotein made in the small intestine of humans. Although it has many proposed roles in vascular disease, satiety, and chylomicron metabolism, there is no known structural basis for these functions. The ability to associate with lipids may be a key step in apoA-IV functionality. We recently identified a single amino acid, Phe334, which seems to inhibit the lipid binding capability of apoA-IV. We also found that an intact N terminus was necessary for increased lipid binding of Phe334 mutants. Here, we identify Trp12 and Phe15 as the N-terminal amino acids required for the fast lipid binding seen with the F334A mutant. Furthermore, we found that individual disruption of putative amphipathic {alpha}-helices 3–11 had little effect on lipid binding, suggesting that the N terminus of apoA-IV may be the operational site for initial lipid binding. We also provide three independent pieces of experimental evidence supporting a direct intramolecular interaction between sequences near amino acids 12/15 and 334. This interaction could represent a unique "switch" mechanism by which apoA-IV changes lipid avidity in vivo.


Received for publication, May 16, 2007 , and in revised form, August 8, 2007.

* This work was supported by National Institutes of Health Grants HL67093 and HL82734 (to W. S. D.), two predoctoral fellowships from the Ohio Valley Affiliate of the American Heart Association (to M. R. T. and K. J. P.), and a University of Cincinnati graduate research fellowship (to M. R. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Pathology and Laboratory Medicine, University of Cincinnati, 2120 Galbraith Rd., Cincinnati, OH 45237-0507. Tel.: 513-558-3707; Fax: 513-558-1312; E-mail: Sean.Davidson{at}UC.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
M. R. Tubb, L. E. Smith, and W. S. Davidson
Purification of recombinant apolipoproteins A-I and A-IV and efficient affinity tag cleavage by tobacco etch virus protease
J. Lipid Res., July 1, 2009; 50(7): 1497 - 1504.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. B. Massey, H. J. Pownall, S. Macha, J. Morris, M. R. Tubb, and R. A. G. D. Silva
Mass spectrometric determination of apolipoprotein molecular stoichiometry in reconstituted high density lipoprotein particles
J. Lipid Res., June 1, 2009; 50(6): 1229 - 1236.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. R. Tubb, R. A. G. D. Silva, J. Fang, P. Tso, and W. S. Davidson
A Three-dimensional Homology Model of Lipid-free Apolipoprotein A-IV Using Cross-linking and Mass Spectrometry
J. Biol. Chem., June 20, 2008; 283(25): 17314 - 17323.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement